CPGJ’ annual R&D cost sums up 30 million RMB yuan, more than 50% of which has been spent on collaboration with various institutes across China and overseas:

---Working with University of Nebraska (USA), SKCC to set up technology exchange and staff training base.

---Allied with National Institute for the Control of Pharmaceutical and Biological Products, the 2nd Military Medical University and Chinese Military Academy of Medical Sciences to develop new drug quality standardization, key technology and testing methodology.

---Collaborated with dozens of domestic clinical pharmacology bases, including Shanghai Renji Hospital to conduct new drugs’ clinical trials.